Global Biochips Market to Reach $21.36 Billion by 2030 as Personalized Medicine Drives 8.8% CAGR
Updated
Updated · Yahoo Finance · Aug 18
Global Biochips Market to Reach $21.36 Billion by 2030 as Personalized Medicine Drives 8.8% CAGR
1 articles · Updated · Yahoo Finance · Aug 18
Summary
$21.36 billion is the projected size of the global biochips market in 2030, up from $14.01 billion in 2025, according to a MarketsandMarkets forecast.
Personalized medicine and precision diagnostics are the main growth engines, with chronic and infectious disease burdens also lifting demand for biochip-based testing.
Drug discovery, genomics, proteomics and non-invasive tools such as liquid biopsy are widening adoption, while point-of-care testing adds another use case.
AI, machine learning and microfluidics are improving high-throughput analysis and product design, helping biochips move deeper into clinical research and healthcare workflows.
Thermo Fisher, Illumina, Agilent, Roche and QIAGEN are among the major players as companies use product launches, partnerships and emerging-market expansion to compete.